Literature DB >> 22566581

Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia.

Deborah E Barnes1, Kristine Yaffe, Amy L Byers, Mark McCormick, Catherine Schaefer, Rachel A Whitmer.   

Abstract

CONTEXT: Depression and dementia are common in older adults and often co-occur, but it is unclear whether depression is an etiologic risk factor for dementia.
OBJECTIVE: To clarify the timing and nature of the association between depression and dementia.
DESIGN: We examined depressive symptoms assessed in midlife (1964-1973) and late life (1994-2000) and the risks of dementia, Alzheimer disease (AD), and vascular dementia (VaD) (2003-2009) in a retrospective cohort study. Depressive symptoms were categorized as none, midlife only, late life only, or both. Cox proportional hazards models (age as timescale) adjusted for demographics and medical comorbidities were used to examine depressive symptom category and risk of dementia, AD, or VaD.
SETTING: Kaiser Permanente Medical Care Program of Northern California. PARTICIPANTS: Thirteen thousand five hundred thirty-five long-term Kaiser Permanente members. MAIN OUTCOME MEASURE: Any medical record diagnosis of dementia or neurology clinic diagnosis of AD or VaD.
RESULTS: Subjects had a mean (SD) age of 81.1 (4.5) years in 2003, 57.9% were women, and 24.2% were nonwhite. Depressive symptoms were present in 14.1% of subjects in midlife only, 9.2% in late life only, and 4.2% in both. During 6 years of follow-up, 22.5% were diagnosed with dementia (5.5% with AD and 2.3% with VaD). The adjusted hazard of dementia was increased by approximately 20% for midlife depressive symptoms only (hazard ratio, 1.19 [95% CI, 1.07-1.32]), 70% for late-life symptoms only (1.72 [1.54-1.92]), and 80% for both (1.77 [1.52-2.06]). When we examined AD and VaD separately, subjects with late-life depressive symptoms only had a 2-fold increase in AD risk (hazard ratio, 2.06 [95% CI, 1.67-2.55]), whereas subjects with midlife and late-life symptoms had more than a 3-fold increase in VaD risk (3.51 [2.44-5.05]).
CONCLUSIONS: Depressive symptoms in midlife or in late life are associated with an increased risk of developing dementia. Depression that begins in late life may be part of the AD prodrome, while recurrent depression may be etiologically associated with increased risk of VaD.

Entities:  

Mesh:

Year:  2012        PMID: 22566581      PMCID: PMC3704214          DOI: 10.1001/archgenpsychiatry.2011.1481

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  37 in total

1.  Grey-matter lesions and dementia.

Authors:  D C Steffens; J R MacFall; M E Payne; K A Welsh-Bohmer; K R Krishnan
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

Review 2.  History of depression as a risk factor for dementia: an updated review.

Authors:  A F Jorm
Journal:  Aust N Z J Psychiatry       Date:  2001-12       Impact factor: 5.744

3.  Depression in Alzheimer's disease: is there a temporal relationship between the onset of depression and the onset of dementia?

Authors:  Reinhard Heun; Martin Kockler; Ursula Ptok
Journal:  Eur Psychiatry       Date:  2002-09       Impact factor: 5.361

4.  Anxiety, depression and psychosis in vascular dementia: prevalence and associations.

Authors:  C Ballard; D Neill; J O'Brien; I G McKeith; P Ince; R Perry
Journal:  J Affect Disord       Date:  2000-08       Impact factor: 4.839

5.  Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

Authors:  Robert C Green; L Adrienne Cupples; Alex Kurz; Sanford Auerbach; Rodney Go; Dessa Sadovnick; Ranjan Duara; Walter A Kukull; Helena Chui; Timi Edeki; Patrick A Griffith; Robert P Friedland; David Bachman; Lindsay Farrer
Journal:  Arch Neurol       Date:  2003-05

6.  Prevalence of depression among older Americans: the Aging, Demographics and Memory Study.

Authors:  David C Steffens; Gwenith G Fisher; Kenneth M Langa; Guy G Potter; Brenda L Plassman
Journal:  Int Psychogeriatr       Date:  2009-06-12       Impact factor: 3.878

7.  Depressive symptoms and risk of dementia: the Framingham Heart Study.

Authors:  J S Saczynski; A Beiser; S Seshadri; S Auerbach; P A Wolf; R Au
Journal:  Neurology       Date:  2010-07-06       Impact factor: 9.910

8.  Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration.

Authors:  C Dufouil; R Fuhrer; J F Dartigues; A Alpérovitch
Journal:  Am J Epidemiol       Date:  1996-10-01       Impact factor: 4.897

Review 9.  White matter hyperintensities in late life depression: a systematic review.

Authors:  L L Herrmann; M Le Masurier; K P Ebmeier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-23       Impact factor: 10.154

10.  Temporal course of depressive symptoms during the development of Alzheimer disease.

Authors:  R S Wilson; G M Hoganson; K B Rajan; L L Barnes; C F Mendes de Leon; D A Evans
Journal:  Neurology       Date:  2010-07-06       Impact factor: 9.910

View more
  126 in total

1.  Clinicopathological correlates of depression in early Alzheimer's disease in the NACC.

Authors:  Sarah T McCutcheon; Dingfen Han; Juan Troncoso; Vassilis E Koliatsos; Marilyn Albert; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-14       Impact factor: 3.485

2.  Aging and Positive Mood: Longitudinal Neurobiological and Cognitive Correlates.

Authors:  Devyn L Cotter; Samantha M Walters; Corrina Fonseca; Amy Wolf; Yann Cobigo; Emily C Fox; Michelle Y You; Marie Altendahl; Nina Djukic; Adam M Staffaroni; Fanny M Elahi; Joel H Kramer; Kaitlin B Casaletto
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-15       Impact factor: 4.105

3.  Soluble amyloid-β levels and late-life depression.

Authors:  Ricardo S Osorio; Tyler Gumb; Nunzio Pomara
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 4.  Advances in Pharmacotherapy of Late-Life Depression.

Authors:  John L Beyer; Kim G Johnson
Journal:  Curr Psychiatry Rep       Date:  2018-04-07       Impact factor: 5.285

5.  Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression.

Authors:  Meghan Riddle; Guy G Potter; Douglas R McQuoid; David C Steffens; John L Beyer; Warren D Taylor
Journal:  Am J Geriatr Psychiatry       Date:  2017-03-28       Impact factor: 4.105

6.  Depressive Symptoms and Longitudinal Changes in Cognition: Women's Health Initiative Study of Cognitive Aging.

Authors:  Joseph S Goveas; Mark A Espeland; Patricia E Hogan; Hilary A Tindle; Regina A Shih; Jane M Kotchen; Jennifer G Robinson; Deborah E Barnes; Susan M Resnick
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-02-28       Impact factor: 2.680

7.  Risk Factors, Neuroanatomical Correlates, and Outcome of Neuropsychiatric Symptoms in Alzheimer's Disease.

Authors:  Stéphane P Poulin; David Bergeron; Bradford C Dickerson
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Bridging the Translation Gap: From Dementia Risk Assessment to Advice on Risk Reduction.

Authors:  Kaarin J Anstey; Ranmalee Eramudugolla; Diane E Hosking; Nicola T Lautenschlager; Roger A Dixon
Journal:  J Prev Alzheimers Dis       Date:  2015

9.  Perceptions of Risk Factors for Alzheimer Disease Among Community-Dwelling, Nondemented Older African Americans.

Authors:  Crystal M Glover; Shelytia CoCroft; Bryan D James; Lisa L Barnes
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jul-Sep       Impact factor: 2.703

10.  Early Midlife Pulmonary Function and Dementia Risk.

Authors:  Paola Gilsanz; Elizabeth Rose Mayeda; Jason Flatt; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.